SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-14-081362
Filing Date
2014-11-17
Accepted
2014-11-17 16:34:43
Documents
1
Group Members
GEORGE R. ROBERTSHENRY R. KRAVISKKR & CO. L.P.KKR BIOSIMILAR GP LLCKKR BIOSIMILAR L.P.KKR FUND HOLDINGS GP LTDKKR GROUP HOLDINGS L.P.KKR GROUP LTDKKR MANAGEMENT LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D a14-24546_1sc13d.htm SC 13D 329847
  Complete submission text file 0001104659-14-081362.txt   331835
Mailing Address 9 WEST 57TH STREET 41ST FLOOR NEW YORK NY 10019
Business Address 9 WEST 57TH STREET 41ST FLOOR NEW YORK NY 10019 212-230-9742
KKR Fund Holdings L.P. (Filed by) CIK: 0001472698 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address C/O DENNIS M. LANFEAR 201 REDWOOD SHORES PARKWAY, SUITE 200 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 201 REDWOOD SHORES PARKWAY, SUITE 200 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Subject) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88402 | Film No.: 141228274
SIC: 2836 Biological Products, (No Diagnostic Substances)